| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
106.85(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $91.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-10-08 |
4 |
AS |
$110.00 |
$2,278,540 |
D/D |
(20,714) |
54,325 |
|
5% |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-10-08 |
4 |
OE |
$62.76 |
$1,300,011 |
D/D |
20,714 |
55,122 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2020-09-23 |
4 |
AS |
$104.34 |
$999,995 |
D/D |
(9,584) |
43,476 |
|
14% |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2020-09-15 |
4 |
AS |
$107.78 |
$75,662 |
D/D |
(702) |
87,366 |
|
4% |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2020-09-09 |
4 |
AS |
$105.05 |
$1,004,593 |
D/D |
(9,563) |
53,060 |
|
11% |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,727 |
49,040 |
|
- |
|
| Martha Geoffrey |
CEO |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,118 |
81,094 |
|
- |
|
| Wall Brett A. |
EVP & Group Pres Restora Thera |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,576 |
18,856 |
|
- |
|
| Liddicoat John R |
EVP & President of Americas |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,905 |
41,827 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,576 |
74,001 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,453 |
190,563 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,042 |
88,068 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,398 |
57,492 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,117 |
54,325 |
|
- |
|
| Salmon Sean |
EVP & Group President Diabetes |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,932 |
28,041 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,754 |
62,623 |
|
- |
|
| Wall Brett A. |
EVP & Group Pres Restora Thera |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$106,128 |
D/D |
(1,100) |
12,280 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$764,315 |
D/D |
(7,922) |
181,110 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$522,053 |
D/D |
(5,411) |
46,208 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$432,423 |
D/D |
(4,482) |
67,425 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$354,757 |
D/D |
(3,677) |
56,869 |
|
- |
|
| Salmon Sean |
EVP & Group President Diabetes |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$247,857 |
D/D |
(2,569) |
23,109 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$342,890 |
D/D |
(3,554) |
44,313 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$263,101 |
D/D |
(2,727) |
50,094 |
|
- |
|
| Martha Geoffrey |
CEO |
• • – |
2020-07-31 |
4 |
D |
$96.48 |
$410,233 |
D/D |
(4,252) |
57,976 |
|
- |
|
680 Records found
|
|
Page 10 of 28 |
|
|
0.49 (0.62%) 
